Regenxbio: Q1 Earnings Snapshot

By The Associated Press
May 14, 2026 | 7:21 AM

ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $90.1 million in its first quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.72.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.36 per share.

The biotechnology company posted revenue of $6.4 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $23.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX

Rybakina overpowers Osaka, will face Zheng in US Open quarterfinals with a chance to become No. 1

By The Associated Press
September 7, 2026 | 5:44 PM

NEW YORK (AP) — Elena Rybakina overpowered Naomi Osaka at the U.S. Open and is a win away from the No. 1 ranking in women's tennis. She just has to beat Zheng Qinwen, which won't be easy. Even when Zheng goes down — way, way down — she refuses to stay there. Rybakina advanced to the quarterfinals Monday with a 6-1, 6-4 victory over Osaka in a matchup of power-hitting Grand Slam champions. The No. 2-seeded Rybakina is guaranteed to replace Aryna Sabalenka atop the WTA rankings if she reaches the semifinals in Flushing Meadows. “Of course I want it, I don't know anyone who wouldn’t wish this, but definitely that’s one of my goals,” Rybakina said. “I try to approach the same way, try to do everything I can, fight until the end my next match and let’s see what’s going to happen.”

Related Stories